Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study

Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler

DOI: 10.4274/tnd.2019.33341

Issue: 2019, Volume 25 - Issue 4
0 798

Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease

Tamer Yazar, Hülya Olgun Yazar

DOI: 10.4274/tnd.2019.13334

Issue: 2019, Volume 25 - Issue 3
0 874

The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis

Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal

DOI: 10.4274/tnd.2019.04207

Issue: 2019, Volume 25 - Issue 3
0 690

What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance

Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk

DOI: 10.4274/tnd.2019.93206

Issue: 2019, Volume 25 - Issue 3
0 817

Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?

Bahar Say, Ufuk Ergün

DOI: 10.4274/tnd.2019.87513

Issue: 2019, Volume 25 - Issue 3
0 938

Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes

İpek Güngör Doğan

DOI: 10.4274/tnd.2019.97720

Issue: 2019, Volume 25 - Issue 3
0 696

The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results

Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale

DOI: 10.4274/tnd.2019.75725

Issue: 2019, Volume 25 - Issue 2
0 843

Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia

Tamer Yazar, Hülya Olgun Yazar

DOI: 10.4274/tnd.2019.85698

Issue: 2019, Volume 25 - Issue 2
0 705

The Relationship Between 25 (OH) Vitamin D Level and the Severity of Disease and Sleep Quality in Restless Legs Syndrome

Arife Çimen Atalar

DOI: 10.4274/tnd.2019.25478

Issue: 2019, Volume 25 - Issue 2
0 834

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Halil Önder

DOI: 10.4274/tnd.2019.05925

Issue: 2019, Volume 25 - Issue 2
0 764

Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort

Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu

DOI: 10.4274/tnd.2018.33230

Issue: 2019, Volume 25 - Issue 1
0 838

Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis

Miraç Ayşen Ünsal

DOI: 10.4274/tnd.2019.00187

Issue: 2019, Volume 25 - Issue 1
0 866

Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years

Nefati Kıylıoğlu

DOI: 10.4274/tnd.79836

Issue: 2018, Volume 24 - Issue 3
0 707

Posterior Auricular Muscle Response: Observations in Brainstem Lesions

Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan

DOI: 10.4274/tnd.57255

Issue: 2018, Volume 24 - Issue 3
0 729

False-positive Basilar Artery Fenestration and Sexual Headache

Buse Rahime Hasırcı Bayır, Kemal Tutkavul, Yılmaz Çetinkaya, İbrahim Anıl Tuncer, Hülya Tireli

DOI: 10.4274/tnd.23334

Issue: 2018, Volume 24 - Issue 3
0 590

Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Joob Beuy, Viroj Wiwanitkit

DOI: 10.4274/tnd.86977

Issue: 2018, Volume 24 - Issue 2
0 617

Demographic Characteristics of Stroke Types in Adıyaman

Yaşar Altun, İrfan Aydın, Abdullah Algın

DOI: 10.4274/tnd.94103

Issue: 2018, Volume 24 - Issue 1
0 753

Mortality in Patients with Multiple Sclerosis

Sümeyra Şamlı, Murat Kürtüncü

DOI: 10.4274/tnd.15921

Issue: 2018, Volume 24 - Issue 1
0 724

Fampridine Therapy in Multiple Sclerosis: We Should Think Twice!

Mohamed S A Mohamed

DOI: 10.4274/tnd.65882

Issue: 2018, Volume 24 - Issue 1
0 549

Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis

Burcu Altunrende, Erkingül Birday, Mithat Kasap, Gülşen Akman Demir

DOI: 10.4274/tnd.62144

Issue: 2017, Volume 23 - Issue 4
0 847